Position in NTRA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$5,032,951
+$4,029,804 QoQ
Shares Held
18,541
+269.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#266
of 844 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Empowered Funds, LLC holds $87,729,062 across 20 Diagnostics & Research names. NTRA ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
36,395 | $18,246,993 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
23,171 | $12,271,128 | |
| 3 | GH |
Guardant Health, Inc.
|
59,848 | $8,978,994 | |
| 4 | DHR |
Danaher Corp /De/
|
41,446 | $7,894,632 | |
| 5 | A |
Agilent Technologies, Inc.
|
45,202 | $6,004,178 | |
| 6 | NTRA |
Natera, Inc.
This page
|
18,541 | $5,032,951 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
3,413 | $4,360,139 | |
| 8 | ICLR |
Icon PLC
|
19,738 | $3,428,687 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,032,951 | 18,541 | Shares | Other | 2026-08-17 | |
| 2026-03-31 | $1,003,147 | 5,016 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $1,887,533 | 11,726 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $475,227 | 2,813 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $6,016,005 | 42,543 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $6,034,078 | 38,118 | Shares | Other | 2025-01-28 | |
| 2024-09-30 | $5,326,059 | 41,954 | Shares | Other | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||